Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 29, 2026, titled "Sun Pharma receives approval to manufacture and market semaglutide in Brazil".
Sun Pharmaceutical Industries Limited Press Release Jul 29 2026
Earlier from Sun Pharmaceutical Industries
- Sun Pharmaceutical Industries Limited Press Release Jul 24 2026
- Sun Pharmaceutical Industries Limited Press Release Jul 15 2026